AegirBio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was SEK 1.39 million compared to SEK 5.26 million a year ago. Net loss was SEK 31.51 million compared to SEK 24.72 million a year ago.